chr6-43259264-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032538.3(TTBK1):c.1243G>A(p.Gly415Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,547,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032538.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTBK1 | NM_032538.3 | c.1243G>A | p.Gly415Ser | missense_variant | 11/15 | ENST00000259750.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTBK1 | ENST00000259750.9 | c.1243G>A | p.Gly415Ser | missense_variant | 11/15 | 1 | NM_032538.3 | P3 | |
TTBK1 | ENST00000703836.1 | c.1243G>A | p.Gly415Ser | missense_variant | 10/13 | A2 | |||
TTBK1 | ENST00000304139.6 | n.1252G>A | non_coding_transcript_exon_variant | 10/13 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000157 AC: 3AN: 190652Hom.: 0 AF XY: 0.0000296 AC XY: 3AN XY: 101398
GnomAD4 exome AF: 0.0000122 AC: 17AN: 1395130Hom.: 0 Cov.: 31 AF XY: 0.0000145 AC XY: 10AN XY: 687580
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.1243G>A (p.G415S) alteration is located in exon 11 (coding exon 10) of the TTBK1 gene. This alteration results from a G to A substitution at nucleotide position 1243, causing the glycine (G) at amino acid position 415 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at